Analysts Issue Forecasts for Stevanato Group FY2027 Earnings

Key Points

• KeyCorp forecasts Stevanato Group FY2027 earnings of $0.70 per share, compared with a $0.67 consensus estimate for the current full year.
• The company reported quarterly EPS of €0.16, missing the €0.17 consensus estimate, while revenue was €326.06 million.
• Analyst views remain mixed: Citigroup and UBS cut their price targets, while MarketBeat’s overall consensus rating is Moderate Buy.

Stevanato Group S.p.A. (NYSE:STVN - Free Report) - Research analysts at KeyCorp issued their FY2027 EPS estimates for shares of Stevanato Group in a research note issued on Tuesday, November 3rd. KeyCorp analyst P. Knight anticipates that the company will earn $0.70 per share for the year. The consensus estimate for Stevanato Group's current full-year earnings is $0.67 per share.

Stevanato Group (NYSE:STVN - Get Free Report) last posted its earnings results on Tuesday, November 3rd. The company reported €0.16 earnings per share for the quarter, missing the consensus estimate of €0.17 by (€0.01). The company had revenue of €326.06 million during the quarter. Stevanato Group had a net margin of 11.24% and a return on equity of 10.51%.

A number of other equities research analysts have also recently weighed in on STVN. Citigroup dropped their price objective on Stevanato Group from $26.00 to $20.00 and set a "buy" rating for the company in a research note on Wednesday, November 4th. UBS Group decreased their target price on Stevanato Group from $23.00 to $16.00 and set a "neutral" rating on the stock in a research note on Wednesday, November 4th. Weiss Ratings upgraded Stevanato Group from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, August 27th. William Blair cut Stevanato Group from an "outperform" rating to a "market perform" rating in a report on Wednesday, November 4th. Finally, Deutsche Bank initiated coverage on Stevanato Group in a research report on Wednesday, October 7th. They issued a "hold" rating for the company. Two investment analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy".

Stevanato Group Stock Down 0.2%

NYSE:STVN opened at €14.33 on Friday. Stevanato Group has a 52 week low of €12.05 and a 52 week high of €24.01. The stock's fifty day moving average is €19.23 and its two-hundred day moving average is €17.92. The stock has a market capitalization of $4.34 billion, a price-to-earnings ratio of 24.70, a price-to-earnings-growth ratio of 1.44 and a beta of 0.80. The company has a quick ratio of 1.19, a current ratio of 1.73 and a debt-to-equity ratio of 0.22.

Insiders Place Their Bets

In other Stevanato Group news, Director William Federici purchased 20,000 shares of the firm's stock in a transaction on Monday, November 9th. The stock was bought at an average price of €13.72 per share, with a total value of €274,400.00. Following the transaction, the director directly owned 46,991 shares of the company's stock, valued at approximately €644,716.52. This represents a 74.10% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director E Jr purchased 25,000 shares of the firm's stock in a transaction on Friday, November 6th. The stock was acquired at an average cost of €13.07 per share, with a total value of €326,750.00. Following the transaction, the director directly owned 62,424 shares in the company, valued at €815,881.68. This trade represents a 66.80% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.70% of the stock is owned by company insiders.

Institutional Trading of Stevanato Group

Several hedge funds have recently modified their holdings of the stock. Fifth Third Bancorp grew its stake in Stevanato Group by 22.6% during the 1st quarter. Fifth Third Bancorp now owns 4,196 shares of the company's stock worth $58,000 after purchasing an additional 773 shares in the last quarter. Integrated Wealth Concepts LLC acquired a new stake in Stevanato Group in the 2nd quarter valued at about $59,000. State of Wyoming acquired a new stake in Stevanato Group in the 3rd quarter valued at about $75,000. GW&K Investment Management LLC raised its position in Stevanato Group by 118.3% in the 3rd quarter. GW&K Investment Management LLC now owns 6,086 shares of the company's stock valued at $128,000 after purchasing an additional 3,298 shares in the last quarter. Finally, Diversify Wealth Management LLC boosted its stake in shares of Stevanato Group by 23.9% in the 1st quarter. Diversify Wealth Management LLC now owns 18,353 shares of the company's stock valued at $252,000 after buying an additional 3,543 shares during the period.

About Stevanato Group

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.